Literature DB >> 11802784

A pH-dependent conformational transition of Abeta peptide and physicochemical properties of the conformers in the glial cell.

Yoichi Matsunaga1, Nobuhiro Saito, Akihiro Fujii, Junichi Yokotani, Tadakazu Takakura, Tomoaki Nishimura, Hiroyuki Esaki, Tatsuo Yamada.   

Abstract

In the present study we identified the epitopes of antibodies against amyloid beta-(1-42)-peptide (Abeta1-42): 4G8 reacted with peptides corresponding to residues 17-21, 6F/3D reacted with peptides corresponding to residues 9-14, and anti 5-10 reacted with peptides corresponding to residues 5-10. The study also yielded some insight into the Abeta1-42 structures resulting from differences in pH. An ELISA study using monoclonal antibodies showed that pH-dependent conformational changes occur in the 6F/3D and 4G8 epitopes modified at pH 4.6, but not in the sequences recognized by anti 1-7 and anti 5-10. This was unique to Abeta1-40 and Abeta1-42 and did not occur with Abeta1-16 or Abeta17-42. The reactivity profile of 4G8 was not affected by blockage of histidine residues of pH-modified Abeta1-40 and Abeta1-42 with diethyl pyrocarbonate; however, the mutant [Gln(11)]Abeta1-40 abrogated the unique pH-dependence towards 4G8 observed with Abeta1-40. These findings suggest that these epitopes are cryptic at pH 4.6, and that Glu(11) is responsible for the changes. We suggest that the abnormal folding of 6F/3D epitope affected by pH masked the 4G8 epitope. A study of the binding of metal ions to Abeta1-42 suggested that Cu(2+) and Zn(2+) induced a conformational transition around the 6F/3D region at pH 7.4, but did not affect the region when it was modified at pH 4.6. However, Fe(2+) had no effect, irrespective of pH. Abeta modified at pH 4.6 appeared to be relatively resistant to proteinase K compared with Abetas modified at pH 7.4, and the former might be preferentially internalized and accumulated in a human glial cell. Our findings suggest the importance of microenvironmental changes, such as pH, in the early stage of formation of Abeta aggregates in the glial cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802784      PMCID: PMC1222337          DOI: 10.1042/0264-6021:3610547

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.

Authors:  T H Huang; D S Yang; N P Plaskos; S Go; C M Yip; P E Fraser; A Chakrabartty
Journal:  J Mol Biol       Date:  2000-03-17       Impact factor: 5.469

2.  Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells.

Authors:  H Chung; M I Brazil; T T Soe; F R Maxfield
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

3.  Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation.

Authors:  J Orpiszewski; M D Benson
Journal:  J Mol Biol       Date:  1999-06-04       Impact factor: 5.469

4.  Implication of novel biochemical property of beta-amyloid.

Authors:  D Elbaum; M Brzyska; A Bacia; D L Alkon
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

Review 5.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.

Authors:  J D Harper; P T Lansbury
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

6.  Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

Authors:  D R Borchelt; T Ratovitski; J van Lare; M K Lee; V Gonzales; N A Jenkins; N G Copeland; D L Price; S S Sisodia
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

7.  Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease.

Authors:  S T Liu; G Howlett; C J Barrow
Journal:  Biochemistry       Date:  1999-07-20       Impact factor: 3.162

8.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.

Authors:  H Shao; S Jao; K Ma; M G Zagorski
Journal:  J Mol Biol       Date:  1999-01-15       Impact factor: 5.469

9.  Copper, iron and zinc in Alzheimer's disease senile plaques.

Authors:  M A Lovell; J D Robertson; W J Teesdale; J L Campbell; W R Markesbery
Journal:  J Neurol Sci       Date:  1998-06-11       Impact factor: 3.181

10.  Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture.

Authors:  D M Skovronsky; R W Doms; V M Lee
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

View more
  5 in total

1.  Reversal of temperature-induced conformational changes in the amyloid-beta peptide, Abeta40, by the beta-sheet breaker peptides 16-23 and 17-24.

Authors:  Funda F Bölükbaşi Hatip; Midori Suenaga; Tatsuo Yamada; Yoichi Matsunaga
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

2.  Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma.

Authors:  Xiao-Han Chen; Robert Siman; Akira Iwata; David F Meaney; John Q Trojanowski; Douglas H Smith
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

3.  Molecular polymorphism of Abeta in Alzheimer's disease.

Authors:  Harry Levine; Lary C Walker
Journal:  Neurobiol Aging       Date:  2008-07-10       Impact factor: 4.673

4.  Environmental factors preceding aβ40 monomer to oligomers and the detection of oligomers in Alzheimer's disease patient serum.

Authors:  Yoichi Matsunaga; Midori Suenaga
Journal:  J Amino Acids       Date:  2012-02-08

5.  The link between intraneuronal N-truncated amyloid-β peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism.

Authors:  Janusz Frackowiak; Bozena Mazur-Kolecka; N Carolyn Schanen; W Ted Brown; Jerzy Wegiel
Journal:  Acta Neuropathol Commun       Date:  2013-09-16       Impact factor: 7.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.